Catalera BioSolutions, a pioneering company in the realm of biological pest control, has successfully secured $8 million in Series A funding. This significant financial boost is set to propel the company’s innovative solutions for agriculture and public health to new heights. The funding round, which marks the first close, was led by S2G Ventures and supported by FCC Capital, with a second and final close anticipated by the end of 2024.
The investment is particularly timely for growers of specialty crops, row crops, and organic farms, all of whom are increasingly seeking to reduce their reliance on synthetic chemicals. Catalera BioSolutions, which emerged as an independent entity from the Vancouver-based ag-tech firm Terramera, aims to address this demand with its suite of biological pest control products. These include RANGO® for specialty crops, SOCORO® for row crops, and Vaporpad® for bed bug treatment in home and public settings. The company is also gearing up to introduce new products, such as TRIFECTO®, which has recently been registered in Mexico.
The agricultural industry is at a crossroads, grappling with the adverse effects of synthetic chemicals, including soil degradation, water contamination, and food security risks. The push towards biological alternatives has never been more urgent. Catalera BioSolutions is at the forefront of this movement, offering solutions that promise effective pest control without the environmental and health hazards associated with traditional chemicals. This shift is especially critical for organic and conventional growers who are looking for sustainable methods to manage pests in high-value crops like fruits, vegetables, and grains.
Sanjeev Krishnan, managing partner at S2G Ventures, underscored the transformative potential of Catalera’s technology: “The biologicals market is at a pivotal moment, with farmers reevaluating their use of synthetic chemicals. Catalera’s platform has the potential to drive significant change in the way pest control is approached in agriculture.” This sentiment is echoed by FCC President Justine Hendricks, who highlighted the strategic importance of this investment for the future of Canadian agriculture: “We are excited to support Catalera BioSolutions in advancing innovative solutions that can benefit the entire food and agriculture sector.”
With the backing of FCC Capital, which is making its inaugural foray into the biologicals space, Catalera is well-positioned to scale its operations and continue its trailblazing work in developing new biological products. FCC’s commitment to reinvesting profits into the industry and the communities it serves further amplifies the potential impact of this investment.
Catalera BioSolutions, based in Vancouver, Canada, has over a decade of experience in biological formulations. The company is steadfast in its mission to reduce the agricultural sector’s dependence on synthetic chemicals and to promote more sustainable pest control practices. This aligns seamlessly with the broader objectives of S2G Ventures and FCC Capital, both of whom are dedicated to fostering sustainable and innovative solutions in the food and agriculture sectors.
As the agricultural industry faces mounting pressure to adopt more sustainable practices, Catalera’s advancements in biological pest control offer a promising path forward. The infusion of $8 million in Series A funding not only validates the company’s innovative approach but also sets the stage for a future where pest control is both effective and environmentally responsible.